Expert Review of Hematology

Article	Citations
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon	58
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care	55
Hematological parameters and X-ray exposure among medical radiation workers: a systematic review and meta-analysis	51
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis	41
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome	37
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP	30
Treatment patterns and blood count control in 10,112 patients with polycythemia vera	29
Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management	28
Frequencies of glycosylphosphatidylinositol (GPI)-deficient cells using high-sensitivity flow cytometry as per the 2018 ICCS/ESCCA consensus guideline in patients with hematologic malignancy, aplastic	28
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia	27
What is the future of digital tools to help manage pain in sickle cell disease patients?	26
Do we need more guidance on thrombophilia testing? Challenges and special considerations	21
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management	21
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease	20
Past, present, and future of orthopedic surgery in hemophilia: looking to a world without bleeding and arthropathy in the near future	19
The future of siRNA-mediated approaches to treat von Willebrand disease	17
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B	17
Correlation between hematocrit and the risk of common human cancers: results of a 1999–2020 observational survey and Mendelian randomization analysis	15
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women	15
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management	15
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations	15
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors	15
Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients	15
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A	14
Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective	14

Current trends and future artificial intelligence applications in transfusion medicine: a bibliometric analysis	13
Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera	13
Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review	12
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!	12
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia	12
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia	12
New directions to develop therapies for people with hemophilia	12
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19	11
Patient-centered care in von Willebrand disease: are we there yet?	11
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	11
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management	10
Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study	10
Optimizing long-term joint health in the treatment of hemophilia	10
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria	10
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding	10
Voxelotor for the treatment of sickle cell disease in pediatric patients	10
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?	10
Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review	10
Rivaroxaban plus aspirin after lower–extremity revascularization	10
Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes	10
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations	10
Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies	10
The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders	10
Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours	10
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia	9
What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?	9
A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS	9
The association between hemoglobin level, anemia, and hypertension among adolescents in Sudan: a multicenter cross-sectional study	9
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases	9
The impact of oral health promotion on the quality of life of children with bleeding disorders: fighting misconceptions	8
Bad players in AL amyloidosis in the current era of treatment	8
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors	8
Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients	8
Indicators of an increased risk of therapy-related myeloid neoplasms in lymphoma patients: how can we best evaluate severe impairment of bone marrow function?	8
Real-world treatment patterns and outcomes in people with von Willebrand disease treated prophylactically with recombinant von Willebrand factor in the United States	8
Lived experience experts: a name created by us for us	8
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura	8
Problems faced by people with hemophilia aged 18–35 years in social life: a qualitative study	8
Is the occurrence of deep vein thrombosis related to the fracture site? A two-sample Mendelian randomization study	8
Long-term follow-up of patients with hairy cell leukemia in the south of Iran	8
Role of volumetric analyses on [18F]FDG PET/CT in pediatric Hodgkin lymphoma	8
An update on novel therapies for treating patients with arterial thrombosis	7
Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials	7
Hematological disorders in children with Down syndrome	7
Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?	7
Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia	7
Monoclonal antibodies used for the management of hemataological disorders	7
Advances in our understanding of genetic markers and targeted therapies for pediatric LCH	7
Advancements in targeting CD30 for lymphoma therapy: a historical perspective and future directions	7
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis	7

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders	7
Sickle cell disease in gulf cooperation council countries: a systematic review	7
Novel therapeutics for immune thrombocytopenia: an evolving treatment landscape	7
Genetic variant of endothelial protein C receptor genes and its serum level in B thalassemic children	7
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades	7
Exploring the genetic relationship between deep vein thrombosis and plasma protein: a new research idea	6
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency	6
A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma	6
An observational study of disease management in adult patients with polycythemia vera: results from a large U.S. claims database	6
Targeting von Willebrand disease: the current status and future directions of management therapies	6
Challenges in the diagnosis of thrombotic thrombocytopenic purpura	6
Curative effect of motherwort combined with ethinylestradiol-cyproterone acetate on dysfunctional uterine bleeding	6
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia	6
Kompetitive allele specific PCR (KASP) based genotyping of sickle gene in the selected sub-ethnic tribal population of Gujarat and Madhya Pradesh	6
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin	6
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them	6
Identifying prognostic gene panels in acute myeloid leukemia	6
Reassuring clinicians and patients using SGLT-2 inhibitors: is there a need to worry about blood complications?	6
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway	6
Stem cell boost for immune effector cell associated hematotoxicity in multiple myeloma: minimizing long-term complications and expanding post CAR T-cell therapy relapse options	6
Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia	6
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes	6
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia	6
Real-world analysis and cost-effectiveness of iron chelation therapy adherence in transfusion-dependent thalassemia	6
May obesity increase the risk of lymphoma? Insights from genetic evidence	6
Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma	6
Evaluating quality-of-life outcomes during decitabine therapy in older adults with acute myeloid leukemia: overview of reported studies and assessment instruments	6
Exploring health disparities in diagnosing multiple myeloma	6
Navigating the gap between guidelines and practical challenges in selecting first-line therapy for chronic lymphocytic leukemia	6
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors	6
The role of staging in multiple myeloma	5
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States	5
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma	5
Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension	5
How clinicians and persons with hemophilia may approach shared decision-making	5
Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations?	5
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review	5
A new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications?	5
Effectiveness of myofascial therapy (MFT) along with traditional physiotherapy and intermittent prophylaxis on short-term improvement of joint health in hemophilic arthropathy: a randomized control tr	5
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response	5
Vasculopathy among children and adolescents with sickle cell disease: the crosstalk with annexin A1, vitamin D, and myocardial iron overload	5
Procalcitonin as a diagnostic marker for infection in sickle cell disease	5
Proactive measures to reduce maternal mortality and post-partum hemorrhage in sub-Saharan Africa: the hematology perspective	5
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review	5
NSAIDS/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy	5
The prognostic power of MMP-9 in diffuse large B-cell lymphoma	4
Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients	4
Five decades of successive establishment of hemophilia care in Thailand	4
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis	4
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies	4
An evaluation of fedratinib for adult patients with newly diagnosed and previously treated myelofibrosis	4
Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods	4
A deep dive into future therapies for microcytic anemias and clinical considerations	4
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature	4
t(4;14), and revised myeloma comorbidity index as good predictors of survival for multiple myeloma	4
CD8+CD25+ Tregs as a predictor of glucocorticoid sensitivity in patients with immune thrombocytopenia	4
Gene polymorphisms predicting response to hydroxyurea treatment in Bahraini patients with sickle cell disease	4
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis	4
Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia	4
The promise of novel treatments for severe chronic neutropenia	4
Inhibitor eradication and treatment for acquired hemophilia A	4
Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights	4
Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility	4
Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study	4
Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia	4
Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?	4
Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapy	4
The past, the present and the future of immune checkpoints inhibitors in multiple myeloma	4
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment	4
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies	4
Managing patients with myelofibrosis and thrombocytopenia	4
Letter to the Editor on “Hematopoietic cell transplants in resource-poor countries: challenges and opportunities”	4
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia	4
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes	4
Foreword: a special focus on bleeding disorders	3
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection	3
Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphoma	3
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review	3
Clinical study on the prevention of deep vein thrombosis in patients with external fixation of lower limb fractures using an automatic ankle pump movement ceramic moxibustion rehabilitation device	3
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias	3

Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary	3
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review	3
The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy	3
Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease	3
Update on iron supplementation in patients with cancer-related anemia	3
Lower rates of maternal morbidities among pregnant women suffering from sickle cell disease who are exposed to hydroxyurea, a retrospective study from tribal area of Western India	3
The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary	3
Masked polycythemia vera: diagnostic challenges and clinical implications	3
Complex interaction of δ-globin variant HbA 2 -Famagusta combined with β-globin variant Hb Monroe in cis with the HBB:c.-92C>G muta	3
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?	3
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia	3
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care	3
Soliciting international perspectives on an American national research agenda for inherited bleeding disorders	3
New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia	3
Correction	3
Subclinical myocardial dysfunction in essential thrombocythemia: role of global longitudinal strain	3
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents	3
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria	3
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding	3
Next generation anticoagulants: a spotlight on the potential role of activated factors XII and XI	3
Mechanism regulation of endoplasmic reticulum stress in multiple myeloma cells: modulation of the UPR, UPS, autophagy, HSPs, and potential therapeutic targets	3
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis	3
To enhance the detection of aplastic anemia in primary care settings: a population-based study in Italy	3
Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia	3
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma	3
Quality of life considerations and management in patients with myelodysplastic syndrome	2
Platelet indices in preeclampsia: comparative analysis with normotensive pregnant women	2
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review	2
Quality of life considerations in myelodysplastic syndrome: not only fatigue	2
Factor first! Emergency department management of persons with hemophilia: a single-center study	2
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia	2
MiR-106b-5p, MiR-200c-3p, and MiR-146a-5p expression as putative biomarkers for disease state in primary immune thrombocytopenia	2
Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects	2
DNA damage repair in megakaryopoiesis: molecular and clinical aspects	2
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia	2
Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and th	2
Effect of days of age at first blood transfusion on intraventricular hemorrhage in very low and extremely low birth weight infants	2
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?	2
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?	2
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines	2
Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses	2
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management	2
Polycythemia vera: aspects of its current diagnosis and initial treatment	2
Cartilage degeneration in hemophilic arthropathy: to focus on prevention or regeneration?	2
Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations	2
A systematic review of histological characteristics in arterial and venous thrombi	2
Ankle arthrodesis and total ankle replacement in patients with congenital bleeding disorders suffering from severe ankle arthropathy	2
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease	2
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations	2
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia	2
Emicizumab: a novel drug in hemophilia A prophylaxis – a narrative review	2
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?	2
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplan	2
Could targeted gene insertion of factor 9 be a potential durable treatment for Hemophilia B?	2
Predictors of progression to chronicity in newly diagnosed primary immune thrombocytopenia: a retrospective multicenter French study	2
Looking to the future of gene therapy for hemophilia A and B	2
Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma	2
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease	2
Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators	2
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease	2
How will genomic testing impact a clinician’s choice for managing chronic myeloid leukemia?	2
Immune thrombocytopenia: a review on the pathogenetic role of immune cells	2
Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy	2
Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis	2
Identification and management of fetal anemia due to hemolytic disease	2
Preformed anti-HLA DQA1/DQB1 DSA possibly responsible for graft failure in haploidentical stem cell transplantation	2
Determining treatment pathways for older patients with acute myeloid leukemia: patient and clinician perspectives	2
Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura	2
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?	2
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections	2
The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis	2
Synovitis in hemophilia: preventing, detecting, and treating joint bleeds	2
The development of a home-based therapeutic platform for multiple myeloma	1
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment	1
What are the therapeutic options for previously treated myelofibrosis?	1
Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia	1
Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?	1
An interview with Dr. Jean A. Yared on his experience as an investigator for obecabtagene autoleucel - by Reegan Burnell-Clarke (Commissioning Editor)	1
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study	1
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma	1
Trends in non-Hodgkin lymphoma mortality: global, regional, and national insights from 1990 to 2021	1
Applications of artificial intelligence to myeloproliferative neoplasms: a narrative review	1
Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma Australia	1
Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis	1
Blood clot prevention in patients with lower limb immobilisation: should low-risk patients receive medication?	1
Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	1
A systematic review of the predicted outcomes related to hematopoietic stem cell transplantation: focus on applied machine learning methods’ performance	1
Advances in therapeutic strategies for primary CNS B-cell lymphomas	1
Clinical decisions and factors influencing the management of persons with hemophilia requiring antithrombotic therapy: a qualitative study	1
Cross-cultural assessment of the influence of the COVID-19 pandemic on the perceived mental health and medical experiences of persons with inherited bleeding disorders and their parents/guardians	1
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A	1
Mucosal toxicity in hematological malignancies: prevention, management, and novel therapeutic insights	1
Efficacy of azacitidine in preventing relapse after hematopoietic stem cell transplantation for advanced myeloid malignancies: a systematic review and meta-analysis	1
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review	1
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians	1